ARTICLE | Company News
Mesoblast, Osiris deal
April 14, 2014 7:00 AM UTC
Osiris said it received $15 million in cash from Mesoblast under a 2013 deal in which Mesoblast acquired Osiris' culture-expanded mesenchymal stem cell (MSC) business. Last year, Osiris received a $15...